Zobrazeno 1 - 4
of 4
pro vyhledávání: '"F J, Melón Rey"'
Autor:
J L, Moyano Calvo, F, Teba del Pino, J, Sanz Sacristán, M, Fernández Arjona, R, Arellano Gañan, M, Rabadán Ruiz, L, Herrero Torres, F J, Melón Rey, I, Pereira Sanz
Publikováno v:
Archivos espanoles de urologia. 48(1)
The present study was conducted to determine the usefulness of prophylactic therapy with alpha 2b interferon for superficial bladder tumors.Following complete TUR, alpha 2b infereron was administered to 36 patients at a dose of 50 million IU weekly f
Publikováno v:
Archivos espanoles de urologia. 47(8)
From 1984 to 1991, fifty-one patients completed prophylactic endovesical treatment with mitomycin C after transurethral resection of a bladder carcinoma Ta, Tl. The mean disease-free period was 31.2 months; twenty patients had recurrences (39.2%) and
Autor:
J L, Moyano Calvo, M, Fernández Arjona, R, Minguez Martínez, M, Rabadan Ruiz, F J, Melón Rey, L, Herrero Torres, I, Pereira Sanz
Publikováno v:
Actas urologicas espanolas. 18(2)
Contribution of our experience in 66 patients included in a prospective randomized study to compare the efficacy of Mitomycin C (MMC) and Alpha 2B Interferon (IFN) in the prevention of relapse of vesical surface tumours. Thirty-five patients were inc
Autor:
J L, Moyano Calvo, R, Arellano Gañán, A, Sempere Gutiérrez, J, Sanz Sacristán, F, Teba del Pino, F J, Melón Rey, L, Herrero Torres, I, Pereira Sanz
Publikováno v:
Archivos espanoles de urologia. 45(6)
Aztreonam is a monobactam antibiotic with a very specific spectrum of action for gram-negative aerobic bacteria. Since these bacteria are responsible for most of the urinary tract infections, we conducted a study to determine its efficacy in the prop